Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01134081 · ClinicalTrials.gov registry record · NA
Expression of Angiogenic Biomarkers During Healing of Intra-Oral Soft Tissue Engineered Grafts
A NA study of Gingival Recession, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT01134081 is a NA study of Gingival Recession that has completed, run by University of Michigan. The registered enrollment target is 44 participants, above the 29-participant average among 10 other Gingival Recession trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01134081, a NA study of Gingival Recession, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this observational research study is to understand more about wound healing of gum tissue. This study was the biomarker study of a small cohort of study participants derived from NCT01547962 (completed). Two surgical sites of each patient were randomly selected to receive CelTx™ as a donor material in one site and conventional autograft using keratinized tissue from the palate as the donor material at the contralateral (opposite side) site. Fluids collected from between a tooth and the gum and directly from wounds contain proteins that occur in different levels as the wound healing process proceeds. In this research study wound fluid will be collected from the donor palate site (roof of your mouth) and the treated sites on your gum before and after placement of CelTx and conventional treatment (tissue from the roof of your mouth) to measure which proteins and how much of each are present during the first 4 weeks of wound healing.
Conditions Studied
Interventions
- BIOLOGICAL CelTx™
- PROCEDURE Free Gingival Graft
Study Locations (1)
Michigan
- Michigan Center for Oral Health Research - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01134081
The ClinicalTrials.gov registry entry for NCT01134081 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 29-participant average among 10 other Gingival Recession trials with a reported enrollment target (52% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gingival Recession appearing as the primary indexed condition, and to 2 interventions - of which CelTx™ is the first listed.
NCT01134081 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01134081 about?
NCT01134081 is a clinical study titled "Expression of Angiogenic Biomarkers During Healing of Intra-Oral Soft Tissue Engineered Grafts". The purpose of this observational research study is to understand more about wound healing of gum tissue. This study was the biomarker study of a small cohort of study participants derived from NCT01547962 (completed). Two surgical sites of each patient were randomly selected to receive CelTx™ as a ...
What is the current status of trial NCT01134081?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2008-01. Estimated completion is 2008-12.
What conditions does trial NCT01134081 study?
This clinical trial studies the following conditions: Gingival Recession.
What interventions are being tested in trial NCT01134081?
The interventions under investigation include: CelTx™ (BIOLOGICAL), Free Gingival Graft (PROCEDURE).
Who is sponsoring clinical trial NCT01134081?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01134081 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingival Recession
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gain of Keratinized Mucosa Around Teeth and Dental Implants Using a Combination of Strip Gingival Graft and Acellular Dermal Matrix
RECRUITING · NA
-
Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
RECRUITING · NA
-
Changes of Soft Tissue Grafting: A Randomized Study
RECRUITING · NA
-
A Comparison of Side Access Mucosal Releasing Incision (SAMRI) and Sulcular Tunnel Access to Treat Gingival Recession.
ACTIVE NOT RECRUITING · NA
-
Thick vs. Thin Acellular Dermal Matrix (ADM)
COMPLETED · NA
-
Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.